Abstract
This chapter interrogates how assumptions about biomedical HIV prevention configure social factors as largely secondary to effectiveness, either as barriers to rollout and uptake of treatment as prevention (TasP), or as the pliable conduits for the same processes. They also gloss over the reflexivity of people who are the subjects of biomedical HIV prevention, ignoring the often unanticipated effects it may have in their social and sexual lives. Like previous approaches to HIV prevention, a biomedical approach needs to engage with the limitations inherent in the assumptions it makes and view itself as open to modification. In doing so, there may be value in understanding biomedical HIV prevention as an assemblage of biomedical, social and political forces and effects, each of which is necessary for it to effectively serve all who are in need of it.
| Original language | English |
|---|---|
| Title of host publication | Remaking HIV Prevention in the 21st Century |
| Editors | Sarah Bernays, Adam Bourne, Susan Kippax, Peter Aggleton, Richard Parker |
| Place of Publication | Cham Switzerland |
| Publisher | Springer |
| Chapter | 3 |
| Pages | 35-45 |
| Number of pages | 11 |
| ISBN (Print) | 9783030698188 |
| DOIs | |
| Publication status | Published - 2021 |
Publication series
| Name | Social Aspects of AIDS |
|---|
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver